Skip to main content

nl
fr
en

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Notification of adverse reactions or incidents

Home
Veterinary medicines
Medicines
Medicines
Marketing Authorisation procedures
Practical informations

Medicines
- Medicines
Particular products
Health products
- Distribution

Practical informations

New Belgian nationale rules concerning harmonization of the SPC, labeling and package leaflet

Last updated on 09/01/2018

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

23/04/2019

PRAC April 2019 – EMA review of the multiple sclerosis medicine LEMTRADA® (alemtuzumab)

18/04/2019

Flash VIG-news: domperidone: no longer approved for use in children due to a lack of efficacy

17/04/2019

Brexit: medicines and medical devices, what is the impact for the pharmaceutical industry and the medical devices industry?

17/04/2019

Brexit: medicines and medical devices, what is the impact for the patient?

All news

© 2016 - FAMHP

Site map
Disclaimer
Complaints
Contact